Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 233

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Treatment of epidemic and pandemic influenza with neuraminidase and M2 proton channel inhibitors

Open access
Oxford, J.S., Bossuyt, S., Balasingam, S., Mann, A., Novelli, P., Lambkin, R.·2003·Clinical Microbiology and Infection

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1469-0691.2003.00564.x

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 32

  1. Davies, 1964, Antiviral activity of 1-ada mantanamine (amantadine), Science, 144, 826, 10.1126/science.144.3620.862 · DOI · Paper page
  2. Hay, 1985, The molecular basis of the specific anti-influenza action of amantadine, EMBO J, 4, 3021, 10.1002/j.1460-2075.1985.tb04038.x · DOI · Paper page
  3. Aoki, 1988, Clinical pharmacokinetics of amantadine hydrochloride, Clin Pharmacokinet, 14, 35, 10.2165/00003088-198814010-00003 · DOI · Paper page
  4. Oxford, 1984, Anti influenza virus activity of amantadine, Viral Chemother, 1, 169
  5. Welliver, 2001, Effectiveness of oseltamivir in preventing influenza in household contacts, JAMA, 285, 748, 10.1001/jama.285.6.748 · DOI · Paper page
  6. Hayden, 2000, Inhaled zanamivir for the prevention of influenza in families, N Engl J Med, 343, 778, 10.1056/NEJM200011023431801 · DOI · Paper page
  7. Reuman, 1989, Efficacy and safety of low dose amantadine hydrochloride as prophylaxis for influenza A, Antiviral Res, 11, 27, 10.1016/0166-3542(89)90018-1 · DOI
  8. Oxford, 1970, In vivo selection of an influenza A2 strain resistant to amantadine, Nature Lond, 226, 82, 10.1038/226082a0 · DOI
  9. Smorodintsev, 1970, Evaluation of amantadine in artificially induced A2 and B influenza, JAMA, 213, 1448, 10.1001/jama.1970.03170350016003 · DOI
  10. Younkin, 1983, Reduction in fever in young adults with influenza A/Brazil 78, H1, N1 infection after treatment with aspirin or amantadine, Antimicrob Agents Chemother, 23, 577, 10.1128/AAC.23.4.577 · doi:10.1128/aac.23.4.577
  11. Sears, 1987, Protective efficacy of low dose amantadine in adults challenged with wild-type influenza A virus, Antimicrob Agents Chemother, 31, 1470, 10.1128/AAC.31.10.1470 · DOI
  12. Laver, 1964, Structural studies on the protein subunits from three strains of influenza virus, J Mol Biol, 9, 109, 10.1016/S0022-2836(64)80094-2 · DOI · Paper page
  13. Colman, 1983, Structure of the catalytic and antigenic sites in influenza virus neuraminidase, Nature, 303, 41, 10.1038/303041a0 · DOI · Paper page
  14. Meindl, 1969, Hoppe Seyler's Z Physiol Chem, 350, 1088, 10.1515/bchm2.1969.350.2.1088 · DOI
  15. Laver, 1999, Disarming flu viruses, Scientific Am, 280, 78, 10.1038/scientificamerican0199-78 · doi:10.1038/scientificamerican0199-78
  16. Ives, 2002, The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo, Antiviral Res, 55, 307, 10.1016/S0166-3542(02)00053-0 · DOI · Paper page
  17. Gubareva, 2000, Influenza virus neuraminidase inhibitors, Lancet, 355, 827, 10.1016/S0140-6736(99)11433-8 · DOI · Paper page
  18. Mendel, 1997, GS 4071 is a potent and selective inhibitor of the growth and neuraminidase activity of influenza A and B virus in vitro, Antiviral Res, 34, A73, 10.1016/S0166-3542(97)83251-2 · doi:10.1016/s0166-3542(97)83251-2
  19. Brouillette, 1999, Design of benzoic acid inhibitors of influenza neuraminidase containing a cyclic substitution for the N-acetyl grouping, Bioorganic Med Cem Lett, 9, 1901, 10.1016/S0960-894X(99)00318-2 · DOI
  20. Luo, 1997, Design of aromatic inhibitors of influenza virus neuraminidase, J Infect Dis, 176, S62, 10.1086/514178 · DOI
  21. Kim, 1998, Structure–activity relationship studies of novel carbocyclic influenza neuraminidase inhibitors, J Med Chem, 41, 2451, 10.1021/jm980162u · DOI · Paper page
  22. Hayden, 1996, Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza, JAMA, 275, 24, 10.1001/jama.1996.03530280047035 · DOI · Paper page
  23. Makela, 2000, Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomised, double-blind, placebo-controlled European study, J Infect, 40, 42, 10.1053/jinf.1999.0602 · DOI · Paper page
  24. Monto, 1999, Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza A and B virus infections, J Infect Dis, 180, 254, 10.1086/314904 · DOI · Paper page
  25. Oxford, 1998, Targeting influenza virus neuraminidase—a new strategy for antiviral therapy, Drug Discovery Today, 3, 448, 10.1016/S1359-6446(98)01241-0 · DOI
  26. Nicholson, 2000, Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial, Lancet, 355, 1845, 10.1016/S0140-6736(00)02288-1 · DOI · Paper page
  27. Treanor, 2000, Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza, JAMA, 283, 1016, 10.1001/jama.283.8.1016 · DOI · Paper page
  28. Oxford, 2001
  29. Public Health Laboratory Service, 1993, Response to a pandemic of influenza: an action plan, PHLS Digest, 10, 147
  30. Oxford, 2000, InfluenzaApandemics of the 20th century with special reference to 1918: virology, pathology and epidemiology, Rev Med Virol, 10, 119, 10.1002/(SICI)1099-1654(200003/04)10:2<119::AID-RMV272>3.0.CO;2-O · DOI
  31. Meltzer, 1999, The economic impact of pandemic influenza in the United States: priorities for intervention, Emerg Infect Dis, 5, 659, 10.3201/eid0505.990507 · DOI · Paper page
  32. Davis, 2000, Ground penetrating radar survey to locate 1918 Spanish flu victims in permafrost, J Forensic Sci, 20, 68, 10.1520/JFS14642J · DOI

Cited by

See all 233

Metadata

Authors
Oxford, J. S., Bossuyt, S., Balasingam, S., Mann, A., Novelli, P., & Lambkin, R.
Venue
Clinical Microbiology and Infection
Publisher
Elsevier BV
Published
2003-01
Volume
9
Issue
1
Pages
1-14
ISSN
1198-743X (ISSN-L)
OpenAlex
W1757353225
Cited by
233
References
4
FWCI
6.95
Type
journal article
Language
en
Open access
bronze
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Treatment of epidemic and pandemic influenza with neuraminidase and M2 proton channel inhibitors. https://app.cochat.ai/papers/10.1046/j.1469-0691.2003.00564.x
The paper
Oxford, J. S., Bossuyt, S., Balasingam, S., Mann, A., Novelli, P., & Lambkin, R. (2003). Treatment of epidemic and pandemic influenza with neuraminidase and M2 proton channel inhibitors. Clinical Microbiology and Infection. https://doi.org/10.1046/j.1469-0691.2003.00564.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.